Positive interaction of the novel β2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 3, 2007, Pages 250-257

  Rossoni, Giuseppe ^a   Manfredi, Barbara ^a   Razzetti, Roberta ^b   Civelli, Maurizio ^b   Berti, Ferruccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Bronchoconstriction; Carmoterol; Guinea pigs; Positive interaction; Tiotropium bromide

Indexed keywords

ACETYLCHOLINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARMOTEROL; HISTAMINE; MUSCARINIC M3 RECEPTOR ANTAGONIST; OVALBUMIN; THROMBOXANE B2; TIOTROPIUM BROMIDE;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BRONCHODILATATION; BRONCHOSPASM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACETYLCHOLINE; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; AMPHETAMINES; ANIMALS; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GUINEA PIGS; HISTAMINE; HYDROXYQUINOLINES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; OVALBUMIN; QUINOLONES; RECEPTORS, ADRENERGIC, BETA-2; SCOPOLAMINE DERIVATIVES; SURVIVAL ANALYSIS; THROMBOXANE B2; TREATMENT OUTCOME;

EID: 33846923601     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.01.004     Document Type: Article

References (33)

1. Disse B., Speck G.A., Rominger K.L., Witek Jr. T.J., and Hammer R. Tiotropium bromide (Spiriva™): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 64 (1999) 457-464
2. Hvizdos K.M., and Goa K.L. Tiotropium bromide. Drugs 62 (2002) 1195-1203
3. 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?. Curr Opin Pharmacol 3 (2003) 270-276
4. 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues. Jpn J Pharmacol 57 (1991) 175-185
5. 2-selective agonist TA-2005. Mol Pharmacol 53 (1998) 128-134
6. 2-agonists. Biol Pharm Bull 17 (1994) 1047-1052
7. 2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea pig. Br J Pharmacol 144 (2005) 422-429
8. 2-agonists. Paediatr Respir Rev 2 (2001) 57-62
9. 3 muscarinic acetylcholine receptor regulation in the airway. Am J Respir Cell Mol Biol 26 (2002) 269-272
10. Bernareggi M., Rossoni G., and Berti F. Bronchopulmonary effects of 8-epi-PGF2a in anaesthetized guinea pigs. Pharmacol Res 37 (1998) 75-80
11. Davies G.E., and Johnston T.P. Quantitative studies on anaphylaxis in guinea-pigs passively sensitized with homologous antibody. Int Arch Allergy Appl Immunol 41 (1971) 648-654
12. Piper P.J., and Vane J.R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 223 (1969) 29-35
13. Erjefält I.A., Wagner Z.G., Strand S.E., and Persson C.G. A method for studies of tracheobronchial microvascular permeability to macromolecules. J Pharmacol Methods 14 (1985) 275-283
14. Erjefält I., and Persson C.G. Inflammatory passage of plasma macromolecules into airway wall and lumen. Pulm Pharmacol 2 (1989) 93-102
15. Tashkin D.P., and Cooper C.B. The role of long-acting bronchodilators in the management of stable COPD. Chest 125 (2004) 249-259
16. Cazzola M., Di Marco F., Santus P., Boveri B., Verga M., Matera M.G., et al. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther 17 (2004) 35-39
17. Cazzola M., Centanni S., Santus P., Verga M., Mondoni M., di Marco F., et al. The functional impact of adding salmeterol and tiotropium in patients with stable COPD. Respir Med 98 (2004) 1214-1221
18. van Noord J.A., de Munck D.R., Bantje T.A., Hop W.C., Akveld M.L., and Bommer A.M. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. Eur Respir J 15 (2000) 878-885
19. Westby M., Berson M., and Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 3 (2004) CD003269
20. Cazzola M., Centanni S., and Donner C.F. Anticholinergic agents. Pulm Pharmacol Ther 11 (1998) 381-392
21. Bolulet L.P., Becker A., Berube D., Beveridge R., and Ernst P. Summary of the recommendations of the Canadian Consensus Conference on Asthma 1999. Canadian Asthma Consensus Group. CMAJ 161 11 Suppl. (1999) S1-S12
22. Gross N.J., and Morton S.S. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 129 (1984) 856-870
23. 2 in lung. Bull Eur Physiopathol Respir 17 (1981) 509-521
24. Kaliner M., Orange R.P., and Austen F.K. Immunological release of histamine and slow-reactive substance of anaphylaxis from human lung. J Exp Med 136 (1972) 556-567
25. Gross N.J., and Skorodin M.S. Role of parasympathetic system in airway obstruction due to emphysema. N Engl J Med 311 (1984) 421-425
26. Morrison J.F.J., Pearson S.B., and Dean H.G. Parasympathetic nervous system in nocturnal asthma. BMJ 296 (1988) 1427-1429
27. 2-adrenergic agonists in COPD. Chest 120 (2001) 258-270
28. Sato E., Koyama S., Okubo Y., Kubo K., and Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 18 (1998) L970-L979
29. Brichetto L., Song P., Crimi E., Rehder K., and Brusisco V. Modulation of cholinergic responsiveness through the β-adrenoceptor signal transmission pathway in bovine trachealis. J Appl Physiol 95 (2003) 735-741
30. Gandevia B. Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J 51 (1975) 13-20
31. Simonsson B.G. Anticholinergic drugs: a review. Scand J Respir Dis 101 (1977) 147-153
32. Lichtenstein L.M. Mediator release and asthma. In: Lichtenstein L.M., and Austen K.F. (Eds). Asthma, physiology, immunopharmacology and treatment (1977), Academic Press, New York 93
33. 4 antagonism: a therapy for chronic allergy?. Br J Pharmacol 142 (2004) 5-7